Go Pro
NASDAQ:COSM

Cosmos Health (COSM) Stock Price, News & Analysis

Cosmos Health logo
$0.40 0.00 (-0.39%)
As of 09:33 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Cosmos Health Stock (NASDAQ:COSM)

Advanced

Key Stats

Today's Range
$0.41
$0.41
50-Day Range
$0.18
$0.41
52-Week Range
$0.16
$1.32
Volume
260,965 shs
Average Volume
4.31 million shs
Market Capitalization
$40.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Cosmos Health Inc. is a global healthcare group focused on pharmaceuticals, nutraceuticals and healthcare-related services. The company develops, manufactures and distributes branded and generic pharmaceutical products, over-the-counter medicines, medical devices and nutritional supplements through its subsidiaries and commercial partners.

Cosmos Health’s portfolio includes Sky Premium Life, a line of premium nutritional supplements, as well as pharmaceutical manufacturing operations associated with Cana Laboratories in Greece. Its businesses serve customers and distribution channels in markets including Europe, the United Kingdom, Greece and the United States, although product availability varies by geography and regulatory requirements.

Founded in 2009, Cosmos Health has expanded through the development of its own healthcare brands and acquisitions in the pharmaceutical and healthcare sectors. The company is led by Greg Siokos, who serves as chief executive officer and has been associated with the company since its founding.

AI Generated. May Contain Errors.

Cosmos Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

COSM MarketRank™: 

Cosmos Health scored higher than 22% of companies evaluated by MarketBeat, and ranked 805th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cosmos Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Cosmos Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cosmos Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Cosmos Health are expected to grow in the coming year, from ($0.21) to $0.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cosmos Health is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cosmos Health is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cosmos Health has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cosmos Health's valuation and earnings.
  • Percentage of Shares Shorted

    5.49% of the float of Cosmos Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Cosmos Health has a short interest ratio ("days to cover") of 1.48, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cosmos Health has recently increased by 7.29%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cosmos Health does not currently pay a dividend.

  • Dividend Growth

    Cosmos Health does not have a long track record of dividend growth.

  • Search Interest

    5 people have searched for COSM on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $207,896.00 in company stock, which represents 0.5081% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Cosmos Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $207,896.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    26.15% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    12.61% of the stock of Cosmos Health is held by institutions.

  • Read more about Cosmos Health's insider trading history.
Receive COSM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cosmos Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

COSM Stock News Headlines

While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starfighter aircraft, giving it a rare platform for high-speed flight testing, captive-carry missions and aerospace research. Its Wind Tunnel in the Sky concept exposes hardware to real high-speed atmospheric conditions, while new collaborations with Vaya Defense & Space and The Bionetics Corporation expand its reach into propulsion, hypersonic test articles and payload processing. FJET is also developing STARLAUNCH, an air-launched system targeting suborbital missions, positioning the company across testing, defense and launch.tc pixel
Cosmos Health: A Company Transformed — 2026 Year-to-Date
See More Headlines

COSM Stock Analysis - Frequently Asked Questions

Cosmos Health's stock was trading at $0.4980 on January 1st, 2026. Since then, COSM shares have decreased by 18.4% and is now trading at $0.4066.

Cosmos Health Inc. (NASDAQ:COSM) issued its quarterly earnings results on Wednesday, August, 19th. The company reported ($0.10) EPS for the quarter, hitting analysts' consensus estimates of ($0.10). The firm had revenue of $19.32 million for the quarter, compared to the consensus estimate of $18.99 million. Cosmos Health had a negative net margin of 33.08% and a negative trailing twelve-month return on equity of 56.88%.

Cosmos Health shares reverse split before market open on Thursday, December 15th 2022.The 1-25 reverse split was announced on Thursday, December 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Top institutional shareholders of Cosmos Health include BlackRock Inc. (0.45%). Insiders that own company stock include Grigorios Siokas and Georgios Terzis.
View institutional ownership trends
.

Shares of COSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cosmos Health investors own include Meta Platforms (META), NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET) and Builders FirstSource (BLDR).

Company Calendar

Last Earnings
8/19/2026
Today
9/24/2026
Next Earnings (Estimated)
11/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Distributors
Current Symbol
NASDAQ:COSM
CIK
1474167
Fax
N/A
Employees
163
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.15 million
Net Margins
-33.08%
Pretax Margin
-33.08%
Return on Equity
-56.88%
Return on Assets
-18.03%

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
1.05
Quick Ratio
0.92

Sales & Book Value

Annual Sales
$65.27 million
Price / Sales
0.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
100,630,000
Free Float
74,318,000
Market Cap
$40.92 million
Optionable
Optionable
Beta
4.80
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:COSM) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners